Get the Stockscreener App
5.49
6.79%
-0.40
After Hours:
5.49
Health Catalyst Inc stock is traded at $5.49, with a volume of 703.57K.
It is down -6.79% in the last 24 hours and down -25.81% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$5.89
Open:
$5.89
24h Volume:
703.57K
Relative Volume:
1.11
Market Cap:
$334.05M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-3.66
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-0.54%
1M Performance:
-25.81%
6M Performance:
-7.42%
1Y Performance:
-44.77%
1-Day Range:
$5.42
$5.89
1-Week Range:
$5.3202
$5.90
52-Week Range:
$5.3202
$10.31
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
5.49 | 334.05M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst COO sells $30,007 in stock - Investing.com
(HCAT) Technical Pivots with Risk Controls - Stock Traders Daily
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services - Healthcare IT Today
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host Conference Call on Wednesday, February 26, 2025 - The Manila Times
Health Catalyst to Announce Fourth Quarter and Full Year 2024 Operating Results and Host ... - The Bakersfield Californian
Q4 2024 Earnings Alert: Health Catalyst Schedules Critical Year-End Results - StockTitan
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Healthcare Tech Giant Health Catalyst Takes Center Stage at BTIG's Elite Medical Conference - StockTitan
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound - MSN
How to Take Advantage of moves in (HCAT) - Stock Traders Daily
Nepsis Inc. Lowers Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
With 87% ownership of the shares, Health Catalyst, Inc. (NASDAQ:HCAT) is heavily dominated by institutional owners - Yahoo Finance
Predictive Disease Analytics Market Top Companies StudySAS; - openPR
Canaccord Genuity Group Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $10.00 - Defense World
Winners And Losers Of Q3: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Yahoo Finance
Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst stock target cut, buy rating at Canaccord on developments - Investing.com Australia
Health Catalyst (NASDAQ:HCAT) Given New $10.00 Price Target at Canaccord Genuity Group - MarketBeat
Health Catalyst stock target cut, buy rating at Canaccord on developments By Investing.com - Investing.com South Africa
Breaking Down Health Catalyst: 8 Analysts Share Their Views - Benzinga
Health Catalyst chief people officer sells $37,348 in stock - MSN
Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $37,363.60 in Stock - MarketBeat
Health Catalyst stock hits 52-week low at $5.4 amid market challenges - MSN
Royal Bank of Canada Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $7.00 - Defense World
Insider Sell: Linda Llewelyn Sells Shares of Health Catalyst Inc (HCAT) - GuruFocus.com
Health Catalyst chief people officer sells $37,348 in stock By Investing.com - Investing.com Nigeria
The top deals to know this week - Modern Healthcare
HCATHealth Catalyst, Inc Latest Stock News & Market Updates - StockTitan
Royal Bank of Canada Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst stock target cut to $7 at RBC Capital By Investing.com - Investing.com Canada
M&A: Health Catalyst Acquires Upfront Healthcare Services - HIT Consultant
Modern Health Appoints Former Health Catalyst Executive Adam Brown as CFO to Drive Growth - StockTitan
Health Catalyst (NASDAQ:HCAT) Given New $7.00 Price Target at Royal Bank of Canada - MarketBeat
It's A Story Of Risk Vs Reward With Health Catalyst, Inc. (NASDAQ:HCAT) - Simply Wall St
Health Catalyst to Acquire Upfront Healthcare Services - Yahoo Finance
JPM25, Day 2: News from Nvidia, Tempus AI and Health Catalyst; A look at Children's Health Dallas' expansion plans - Fierce healthcare
Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) PT at $11.45 - MarketBeat
Health Catalyst's SWOT analysis: stock's future hinges on Ignite platform success - Investing.com India
Health Catalyst’s SWOT analysis: stock’s future hinges on Ignite platform success - Investing.com Nigeria
OrthoNebraska Selects Health Catalyst Ignite? to Advance Data-Driven Orthopedic Care - Marketscreener.com
Health Catalyst set to acquire Upfront Healthcare By Investing.com - Investing.com Canada
Health Catalyst set to acquire Upfront Healthcare - Investing.com India
Health Catalyst Buys Upfront, Announces Partnership With Databricks - Healthcare Innovation
Health Catalyst to Buy Upfront Healthcare Services for $86 Million - MarketWatch
OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care - PR Newswire
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.82%
3.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):